StockData

AVAI Bio, Inc. (AVAI) stock

AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026Market cap $17.24MP/E –Yield –

AVAI Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was $276.32K, down 80.7% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2023Mar 31, 2023$276.32K-80.7%
FY2020Mar 31, 2020$1.43M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2021CQ4 2020Dec 31, 2020$309.56K–
Q2 FY2021CQ3 2020Sep 30, 2020$709.21K–
Q1 FY2021CQ2 2020Jun 30, 2020$598.43K–

More AVAI Bio figures

See a number that looks wrong?